

LA JOLLA, CA, Aug. 24, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company developing innovative therapies for inflammatory, fibrotic and autoimmune diseases, today announced that three abstracts and an oral presentation highlighting data from the Phase 2a GRI-0621-IPF-02 study have been selected for presentation at the 2026 European Respiratory Society (ERS) Congress, being held September 5-9, 2026 in Barcelona, Spain.

Bitcoin jumped 4.6% to $72,475.25 – a roughly 12% gain over the past two days after the digital asset was trading near $63,000 earlier this week.

Ingevity Corporation (NYSE: NGVT) today announced it has published its [url="]2025 Sustainability Report[/url] featuring the company's advanced materials and tec

Ingram Micro today released its 2025 Sustainable Impact Report, detailing the company's progress made through 2025 to reduce carbon emissions, advance zero-wast

Williams (NYSE: WMB) today released its 2025 Sustainability Report, highlighting its environmental, safety and operational performance amid rapidly growing dema

Today, Banner Bank released its 2025 Corporate Responsibility Report. The report identifies ongoing practices and recent accomplishments that contribute to crea

Asbury Automotive Group, Inc. (NYSE: ABG), one of the largest automotive retail and service companies in the U.S, is proud to be recognized on TIME's list of A

Luxshare Precision Releases 2025 Sustainability Report PR Newswire NEW YORK, June 23, 2026